Hirotake Tsukamoto
12PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Oct 01, 2025
Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse events.Hirotake Tsukamoto, Kosaku Murakami, Yuji Miura
|Mar 06, 2025
Anti-arthritic effects of polyunsaturated fatty acid-rich supplementation combined with selective soluble epoxide hydrolase inhibitors in a collagen-induced arthritis mouse model.Akiko Yoshida, Kosaku Murakami, Hirotake Tsukamoto
|Jan 11, 2024
Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations.Yusuke Tomita, Shinya Sakata, Kosuke Imamura
|Dec 21, 2022
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.Takahiko Akiyama, Tadahito Yasuda, Tomoyuki Uchihara
|Jul 20, 2022
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events.Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita
|Feb 09, 2022
Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination.Yusuke Miyashita, Takanobu Yoshida, Yuriko Takagi
Pageof 2
Frequent Collaborators
3 joint publications
Satoshi Fukushima
2 joint publications
Yoshihiro Komohara
2 joint publications
Yorifumi Satou
2 joint publications
Hiroyuki Oshiumi
2 joint publications
Yusuke Miyashita
1 joint publications
Satoshi Umemoto
1 joint publications
Akio Morinobu
1 joint publications
Hisashi Kanemaru
1 joint publications
Azusa Miyashita
1 joint publications
Jun-Ichirou Yasunaga
